Compounds | Larval mortality (%) | Emergency adults (%) | CIT/CICa (%) | GRT/GRCb (%) | ECIT/ECICc (%) |
Control | 3 | 97 | - | - | - |
1 | 70 | 30 | 83 ± 11 | 68 ± 12 | 80 ± 16 |
2 | 75 | 25 | 67 ± 10 | 12 ± 1 | 18 ± 5 |
3 | 60 | 40 | 97 ± 6 | 92 ± 15 | 89 ± 11 |
4 | 5 | 95 | 95 ± 8 | 89 ± 14 | 94 ± 11 |
5 | 10 | 90 | 102 ± 4 | 98 ± 17 | 93 ± 12 |
6 | 5 | 95 | 95 ± 4 | 86 ± 10 | 91 ± 9 |
7 | 10 | 90 | 98 ± 11 | 98 ± 11 | 94 ± 13 |
8 | 5 | 95 | 95 ± 2 | 98 ± 6 | 100 ± 5 |
9 | 100 | ND | ND | ND | ND |
10 | 80 | 20 | 53 ± 1 | 33 ± 7 | 62 ± 13 |
11 | 20 | 80 | 76 ± 8 | 74 ± 11 | 94 ± 12 |
12 | 15 | 85 | 72 ± 11 | 77 ± 12 | 97 ± 17 |